BCR-ABL kinase down-regulates ccn3 expression in chronic myeloid leukaemia

被引：0
|
作者：
不详
机构：
来源：
CELLULAR ONCOLOGY | 2005年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Effect of BCR-ABL inhibition on induction of autophagy in chronic myeloid leukaemia cells
    Mackay, C. E.
    Allen, E. K.
    Mukhopadhyay, A.
    Karvela, M.
    Holyoake, T. L.
    Jorgensen, H. G.
    Helgason, G. V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 58 - 58
  • [32] Dual transcripts of BCR-ABL & different polymorphisms in chronic myeloid leukaemia patients
    Nandagopalan, S. Rajashree
    Kuila, Nivedita
    Biswas, Sutapa
    Pattnayak, Naresh Chandra
    Biswas, Gyanashyam
    Chakraborty, Soumen
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 136 - 141
  • [33] Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia
    Hughes, T
    Branford, S
    BLOOD REVIEWS, 2006, 20 (01) : 29 - 41
  • [34] Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells
    Liao, Hui-Fen
    Su, Yu-Chieh
    Zheng, Zhi-Yu
    Cai, Chang Jhih
    Hou, Ming-Hung
    Chao, K. S. Clifford
    Chen, Yu-Jen
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (05) : 378 - 383
  • [35] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Goldman, JM
    Melo, JV
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1084 - 1086
  • [36] Serial but not single BCR-ABL transcript rises are predictive of ABL kinase mutations in chronic myeloid leukaemia patients treated by imatinib
    Wang, L
    Knight, K
    Lucas, CM
    Clark, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 33 - 33
  • [37] BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
    Roy, Swagata
    Jorgensen, Heather G.
    Roy, Poornima
    El Baky, Mohamed Abed
    Melo, Junia V.
    Strathdee, Gordon
    Holyoake, Tessa L.
    Bartholomew, Chris
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 446 - 456
  • [38] Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia
    Manley, PW
    Cowan-Jacob, SW
    Mestan, J
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2): : 3 - 13
  • [39] The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines
    Xu, YX
    Voelter-Mahlknecht, S
    Mahlknecht, U
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 15 (01) : 169 - 172
  • [40] BCR-ABL Mutations in Chronic Myeloid Leukemia
    Ernst, Thomas
    La Rosee, Paul
    Mueller, Martin C.
    Hochhaus, Andreas
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 997 - +
12345